Precision Lung Cancer Survivorship Care Intervention
Part of paid clinical trials in Lexington, Kentucky.
- Sponsor
- Jerod L Stapleton, PhD
- Study ID
- NCT05857995
- Status
- Recruiting
Conditions
- Cancer of Lung
- Cancer of the Lung
- Cancer, Lung
- Cancer, Pulmonary
- Cancers, Lung
- Cancers, Pulmonary
- Lung Cancer
- Lung Cancers
- Neoplasm, Pulmonary
- Neoplasms, Lung
- Neoplasms, Pulmonary
- Pulmonary Cancer
- Pulmonary Cancers
- Pulmonary Neoplasm
- Pulmonary Neoplasms
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program — BEHAVIORALKLCLCSC is a survivor or survivor plus caregiver-focused psychosocial and behavioral intervention designed to engage lung cancer survivors and improve lung cancer outcomes.
- Enhanced Usual Care — BEHAVIORALEUC involves a combination of the standard of care plus a bibliotherapy intervention and assessment.
Study Details
The overarching goal of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program is to reduce the burden of lung cancer by offering an innovative survivorship care approach that improves lung cancer quality of life, overcomes lung cancer stigma, and helps survivors engage with care. The project involves a two-group parallel randomized clinical trial comparing the impact of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program (KLCLCSC) among lung cancer survivors (N=300) against an enhanced usual care condition (bibliotherapy+assessment) on quality of life outcomes.
Key Dates
- Start date
- Aug 16, 2024
- Status verified
- Feb 2026
- Primary completion
- Jul 1, 2027
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 300 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program (KLCLCSC)The Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program (KLCLCSC) is a targeted and tailored lung cancer survivorship care intervention built on principles of patient-centered care, shared decision making, and motivational interviewing to build survivor engagement and improve lung cancer outcomes.
- Active Comparator: Enhanced Usual Care (EUC)The enhanced usual care condition involves usual care plus bibliotherapy and assessment.
Primary Outcome Measure
Change from Baseline (T0) in Mean Lung Cancer Quality of Life at 6 Months (T2) [ Time Frame: Baseline (T0) and 6 Months (T2) ]
Central Contacts
- Jerod L Stapleton, PhD8593237224
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Markey Cancer Center | Lexington | Kentucky | 40536 | Jerod L Stapleton, PhD |
Find similar trials in Lexington, KY
Related Studies
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruiting · Adela, Inc · Duarte, California
- Empathic Communication Skills (ECS) TrainingRecruiting · Memorial Sloan Kettering Cancer Center · Irvine, California
- Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid TumorsPHASE1 · Recruiting · SystImmune Inc. · Beverly Hills, California
- Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer TreatmentRecruiting · Laurie McLouth · Lexington, Kentucky